Literature DB >> 7551383

Factors limiting exercise performance in long-term survivors of bronchopulmonary dysplasia.

P Santuz1, E Baraldi, P Zaramella, M Filippone, F Zacchello.   

Abstract

The long-term impairment of pulmonary function during exercise was assessed in 12 children, aged 6 to 12 yr, who developed BPD after prematurity (gestational age 30 +/- 2 wk [mean +/- SD] and birth weight 1,400 +/- 335 g) and 16 age-, sex-, and physical activity-matched healthy children born at term, who served as controls. The children performed pulmonary function tests at rest and a maximal stepwise exercise on a treadmill. Oxygen consumption (VO2), carbon dioxide output (VCO2), and minute ventilation (VE) were monitored during the run. Baseline mean spirometric values (% of predicted) were in the normal range for both groups but were lower in BPD children with respect to control children (p < 0.05). At rest, arterial oxygen saturation (SaO2) was > or = 98% in all BPD children, but at peak exercise, 4 of them had a SaO2 fall > or = 4%. The postexercise FEV1 fall, with respect to the baseline, was 8 +/- 6%, in BPD and 2 +/- 1% in control children (p < 0.01). Maximum VO2 and VE were significantly lower in BPD children with respect to the control group (25.2 +/- 10.3 versus 37.1 +/- 10.4 ml/min/kg and 20.8 +/- 9.4 versus 30.7 +/- 7.9 L/min, respectively, both p < 0.01). Also, at submaximal levels of exercise dynamic, VO2 and VE responses were significantly lower in the BPD group (ANOVA, p < 0.001), with a ventilatory pattern characterized by lower tidal volumes. Anaerobic threshold was 20.6 +/- 9 in BPD and 28.8 +/- 8.6 ml O2/min/kg in healthy children (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7551383     DOI: 10.1164/ajrccm.152.4.7551383

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease.

Authors:  S Stick
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 3.  Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.

Authors:  Jessica Y Islam; Roberta L Keller; Judy L Aschner; Tina V Hartert; Paul E Moore
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

Review 4.  Exercise and the child born prematurely.

Authors:  H Hebestreit; O Bar-Or
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

5.  Aerobic fitness and physical activity levels of children born prematurely following randomization to postnatal dexamethasone.

Authors:  Patricia A Nixon; Lisa K Washburn; Lanay M Mudd; Heather H Webb; T Michael O'Shea
Journal:  J Pediatr       Date:  2010-08-21       Impact factor: 4.406

Review 6.  Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm.

Authors:  Joseph W Duke; Adam J Lewandowski; Steven H Abman; Andrew T Lovering
Journal:  J Physiol       Date:  2022-01-12       Impact factor: 6.228

Review 7.  Fitness and physical activity in children with asthma.

Authors:  Liam Welsh; Richard G D Roberts; Justin G Kemp
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 9.  Bronchopulmonary dysplasia: an update.

Authors:  Anita Bhandari; Vineet Bhandari
Journal:  Indian J Pediatr       Date:  2007-01       Impact factor: 5.319

10.  Using Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later Life.

Authors:  Megan O'Reilly; Bernard Thébaud
Journal:  Pulm Med       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.